A "cell-free treatment" for tendon injuries: adipose stem cell-derived exosomes
Kexin Lyu,Tianzhu Liu,Yixuan Chen,Jingwei Lu,Li Jiang,Xueli Liu,Xinyue Liu,Yujie Li,Sen Li
DOI: https://doi.org/10.1186/s40001-022-00707-x
IF: 4.981
2022-05-30
European Journal of Medical Research
Abstract:Tendon injuries are widespread and chronic disorders of the musculoskeletal system, frequently caused by overload of the tendons. Currently, the most common treatment for tendon injuries is "cell-free therapy", of which exosomes, which can treat a host of diseases, including immune disorders, musculoskeletal injuries and cardiovascular diseases, are one kind. Among the many sources of exosomes, adipose-derived stem cell exosomes (ASC-Exos) have better efficacy. This is attributed not only to the ease of isolation of adipose tissue, but also to the high differentiation capacity of ASCs, their greater paracrine function, and immunomodulatory capacity compared to other exosomes. ASC-Exos promote tendon repair by four mechanisms: promoting angiogenesis under hypoxic conditions, reducing the inflammatory response, promoting tendon cell migration and proliferation, and accelerating collagen synthesis, thus accelerating tendon healing. This review focuses on describing studies of preclinical experiments with various exosomes, the characteristics of ASC-Exos and their mechanisms of action in tendon healing, as well as elaborating the limitations of ASC-Exos in clinical applications.
medicine, research & experimental